The First Affiliated Hospital With Nanjing Medical University
Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.
-
Hospitals test new weapons against superbugs
Disease control ENROLLING_BY_INVITATIONThis study looks back at hospital records to see how well two newer antibiotics work against tough, drug-resistant bacterial infections. It will include about 400 adult patients who were treated with either eravacycline or tigecycline for at least 3 days. The main goal is to comp…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Blood test guides extra treatment to stop Cancer's return
Disease control ENROLLING_BY_INVITATIONThis study is testing a personalized approach to control advanced esophageal cancer. It uses a blood test to find patients at high risk of the cancer coming back after standard treatment. Those high-risk patients then receive extra treatment with immunotherapy and chemotherapy to…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scarred lungs may change cancer treatment success
Knowledge-focused OngoingThis study aims to understand how having lung scarring (pulmonary fibrosis) affects the results and safety of immunotherapy in people with lung cancer. Researchers will look back at the medical records of 200 patients to compare survival and side effects between those with and wi…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC